Health-related quality of life after interventional or conservative strategy in patients with unstable angina or nonST-segment elevation myocardial infarction
One-year results of the third randomized intervention trial of unstable angina (RITA-3)
Joseph Kim, PhD*,*,
Robert A. Henderson, FRCP
,
Stuart J. Pocock, PhD*,
Tim Clayton, MSc*,
Mark J. Sculpher, PhD
,
Keith A.A. Fox, FESC
RITA-3 Trial Investigators
* Medical Statistics Unit, London School of Hygiene & Tropical Medicine, London, UK
Department of Cardiology, Nottingham City Hospital, Nottingham, UK
Centre for Health Economics, University of York, York, UK
Cardiovascular Research Division of Medical and Radiological Sciences, Royal Infirmary, Edinburgh, United Kingdom

View larger version (12K):
[in a new window]
|
Figure 1 Mean ± SEM values of EuroQOL-Visual Analogue Scale (VAS) at baseline and four-month and one-year follow-up by treatment group. Results for the conservative strategy group are offset for clarity.
|
|

View larger version (13K):
[in a new window]
|
Figure 2 Mean ± SEM values of EuroQOL-Visual Analogue Scale (VAS) for patients classified by their current Canadian Cardiovascular Society (CCS) angina grade and treatment group at four months (a) and one-year follow-up (b). Results for the conservative strategy group are offset for clarity.
|
|
Copyright © 2005 by the American College of Cardiology Foundation.